ERS Respiratory Failure & Mechanical Ventilation · Rotterdam 2026

From physiological insight to bedside decisions

Professor Alexandre Demoule on continuous diaphragm monitoring — why the diaphragm predicts weaning and extubation outcomes, and how objective, continuous measurement can support safer decisions at the bedside.

Invited talk · ERS RFMV 2026 · Prof. Alexandre Demoule, Sorbonne Université / Pitié-Salpêtrière, Paris.

Diaphragm dysfunction is one of the most common — and most overlooked — drivers of weaning failure in the ICU. It develops quickly under mechanical ventilation, it isdifficult to detect clinically, and it carries real consequences for how long patients stayventilated.

In this talk from ERS RFMV 2026 in Rotterdam, Professor Alexandre Demoule walks through the physiology of diaphragm dysfunction, the evidence linking it to weaningand extubation failure, and the studies behind continuous, operator-independentdiaphragm monitoring.

He closes with the question that matters most at the bedside: what does this actually change in practice?

Jump to what matters to you

01

The problem

Why the diaphragm fails under ventilation.

02

The stakes

Its link to weaning & extubation failure.

03

The evidence

Continuous monitoring during the SBT (DE-RISK WF)

04

The technology

DXT demonstrated live on stage.

05

The takeaway

From physiology to bedside decisions.

What the evidence shows

Diaphragm dysfunction is common and consequential. It affects more than 60% of patientson mechanical ventilation — up to around 80% in prolonged ventilation — and is associatedwith weaning failure, prolonged ventilation and longer ICU stays.
It contributes to weaning and extubation failure. Diaphragm dysfunction is a common —and frequently undetected — driver of failed weaning and reintubation, historically hard tomeasure reliably and continuously at the bedside.
Guidelines already point this way. ESICM consensus recommends that estimatingdiaphragmatic excursion be considered a basic skill for intensivists, particularly in patientsbeing weaned from mechanical ventilation.
DXT gives an objective, validated threshold (DE-RISK WF). Continuous DXT monitoringduring the spontaneous breathing trial provides a validated cut-off: a diaphragm excursionbelow 1.1 cm is associated with an ~8x~ higher risk of extubation failure (relative risk 7.9).
It lowers the barrier to routine use. Objective and reproducible, DXT reduces inter-operatorvariability and lowers the technical and training burden versus intermittent, expertisedependentultrasound.

See what he's describing — DXT, live

During the session, DXT was demonstrated live on stage: Two sensors placed non-invasively on the chest and back, then continuous, real-time diaphragm excursion and respiratory rate displayed throughout a spontaneous breathing trial — no ultrasound expertise required at the bedside.

Contact us to discuss clinical use of DXT
The DXT Monitor

About the Expert

Professor Alexandre Demoule is a professor of intensive care medicine at the Sorbonne University, in Paris.

He is the medical director of the medical intensive care unit, the step-down unit and the weaning centre within the Division of Pneumology and Intensive Care Medicine, La Pitié-Salpêtrière teaching hospital in Paris.

As the previous chair of the European Research Network on Mechanical Ventilation (REVA), he is an internationally recognized expert in mechanical ventilation and diaphragm dysfunction and has served as the principal investigator in multiple clinical studies evaluating DXT.

Professor Alexandre Demoule

Every Breath, Measured

Update cookies preferences